Flock — Smart-money disclosures, made readable

United Therapeutics Corp Del

UTHRNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−976 sh · $506.0K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−850 sh · $444.4K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−192 sh · $100.5K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−940 sh · $493.7K
Filed 21 Aug 2026SEC Form 4view source
ACQUIREDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
+2,690 sh · $392.8K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−1,819 sh · $947.8K
Filed 21 Aug 2026SEC Form 4view source
ACQUIREDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
+9,500 sh · $1.3M
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−193 sh · $101.7K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−2,470 sh · $1.3M
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−502 sh · $261.1K
Filed 21 Aug 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show the latest 50

REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,504 sh · $781.3K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−800 sh · $418.6K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−2,690 sh · $1.4M
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−2,357 sh · $1.2M
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−960 sh · $501.5K
Filed 21 Aug 2026SEC Form 4view source
ACQUIREDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
+5,610 sh · $819.2K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−240 sh · $126.0K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−400 sh · $210.6K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−120 sh · $63.3K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahon Paul A
United Therapeutics Corp Del · NASDAQ
−787 sh · $410.8K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,200 sh · $634.3K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−80 sh · $42.5K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−200 sh · $106.5K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−2,105 sh · $1.1M
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−659 sh · $349.0K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−895 sh · $470.4K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−2,135 sh · $1.1M
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−201 sh · $106.7K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−441 sh · $231.3K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−240 sh · $125.4K
Filed 20 Aug 2026SEC Form 4view source
ACQUIREDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
+9,500 sh · $1.3M
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,264 sh · $661.9K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−80 sh · $42.8K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,630 sh · $844.6K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−873 sh · $451.4K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−441 sh · $228.7K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,880 sh · $970.2K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−2,333 sh · $1.2M
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−439 sh · $225.2K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,264 sh · $649.9K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
+9,500 sh · $1.3M
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−231 sh · $117.9K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−239 sh · $121.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−170 sh · $87.0K
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Renaissance Technologies
United Therapeutics Corp Del · NASDAQ
1,708,739 sh · $925.8M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Bridgewater Associates
United Therapeutics Corp Del · NASDAQ
111,326 sh · $60.3M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Bridgewater Associates
United Therapeutics Corp Del · NASDAQ
111,169 sh · $65.9M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Renaissance Technologies
United Therapeutics Corp Del · NASDAQ
1,787,019 sh · $1.06B
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
United Therapeutics Corp Del · NASDAQ
40,576 sh · $24.1M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
United Therapeutics Corp Del · NASDAQ
1,909,259 sh · $930.3M
Filed 31 Dec 2025SEC 13Fview source